Sint Franciscus Gasthuis   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Rotterdam Netherlands (1892)

Organization Overview

First Clinical Trial
2013
NCT01967459
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Sint Franciscus Gasthuis

Active Ingredients

Drugs in Phase 3 Trials (1)

imiquimod (aldara) (1 trial)

Drugs in Phase 2 Trials (4)

isis 678354 (1 trial)

metformin (glucophage) (1 trial)

thiamine (1 trial)

vitamin c (1 trial)

Drugs in Other Trials (3)

ferrous fumarate (1 trial)

iron isomaltoside (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma in Situ (Phase 3)

Cervical Intraepithelial Neoplasia (Phase 3)

Heart Arrest (Phase 2)

Neoplasms (Phase 3)

Urinary Bladder Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 8